These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4395271)

  • 21. [Effect of opioid peptides on the transmission of nociceptive excitation in the spinal cord afferent tracts].
    Kasparov SA
    Farmakol Toksikol; 1983; 46(2):40-4. PubMed ID: 6303837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of opiate peptides on interneuronal transmission in the spinal cord].
    Aliautdin RN; Kasparov SA; Fisenko VP; Chicehnkov ON
    Farmakol Toksikol; 1981; 44(4):406-10. PubMed ID: 6269876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone releasing effects of ACTH and -MSH in man.
    Zahnd GR; Nadeau A; von Mühlendahl KE
    Isr J Med Sci; 1972 Jun; 8(6):874-5. PubMed ID: 4340669
    [No Abstract]   [Full Text] [Related]  

  • 24. The brain as an endocrine organ--update 1981.
    Guillemin R
    Endocrinol Exp; 1982 Nov; 16(3-4):151-62. PubMed ID: 6129125
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuropeptides: influence of acute and chronic effects of opiates.
    Krivoy WA; Kroeger DC; Zimmermann E
    Psychoneuroendocrinology; 1977; 2(1):43-51. PubMed ID: 198832
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of narcotic analgesics of nociceptive transmission in the spinal cord].
    Kasparov SA
    Farmakol Toksikol; 1982; 45(2):30-5. PubMed ID: 6122597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS and ACTH-like peptides: neurochemical response and interaction with opiates.
    Gispen WH; Reith ME; Schotman P; Wiegant VM; Zwiers H; de Wied D
    Adv Biochem Psychopharmacol; 1977; 17():61-80. PubMed ID: 200081
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of releasing factors on hypothalamic neurones.
    Steiner FA
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):275-8. PubMed ID: 208697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral effects of neuropeptides related to ACTH, MSH, and betaLPH.
    de Wied D
    Ann N Y Acad Sci; 1977 Oct; 297():263-74. PubMed ID: 211902
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on synaptic transmission in spinal cord cultures: a comparison of postsynaptic actions of classical neurotransmitters with the peptides.
    Pun RY
    Peptides; 1982; 3(3):249-57. PubMed ID: 6126862
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationships between the structure and biological activities of corticotropin and related peptides: hyperglycemic action of N-acetylated corticotropin related peptides.
    Lebovitz HE; Genuth S; Pooler K
    Endocrinology; 1966 Sep; 79(3):635-42. PubMed ID: 4288529
    [No Abstract]   [Full Text] [Related]  

  • 32. The solid-phase synthesis of human and monkey beta-melanotropins.
    Wang KT; Blake J; Li CH
    Int J Pept Protein Res; 1973; 5(1):33-6. PubMed ID: 4357823
    [No Abstract]   [Full Text] [Related]  

  • 33. The action of reserpine on teleost melanophores.
    Finnin BC; Reed BL
    Eur J Pharmacol; 1973 Jun; 22(3):239-48. PubMed ID: 4354576
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of melanotropic peptides on protein synthesis in mouse brain.
    Rudman D; Scott JW; Del Rio AE; Houser DH; Sheen S
    Am J Physiol; 1974 Mar; 226(3):687-92. PubMed ID: 4361540
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipotropin and the central nervous system.
    Gispen WH; van Ree JM; de Wied D
    Int Rev Neurobiol; 1977; 20():209-50. PubMed ID: 22510
    [No Abstract]   [Full Text] [Related]  

  • 36. Peptides and the conversion of [3H]tyrosine to catecholamines: effects of ACTH-analogs, melanocyte-stimulating hormones and lysine-vasopressin.
    Iuvone PM; Morasco J; Delanoy RL; Dunn AJ
    Brain Res; 1978 Jan; 139(1):131-9. PubMed ID: 202372
    [No Abstract]   [Full Text] [Related]  

  • 37. Melanotropic peptides increase permeability of plasma/cerebrospinal fluid barrier.
    Rudman D; Kutner MH
    Am J Physiol; 1978 Mar; 234(3):E327-32. PubMed ID: 204198
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacology of segmental transmission in the spinal cord.
    Evans RH
    Prog Neurobiol; 1989; 33(4):255-79. PubMed ID: 2573110
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of hydrocortisone and ACTH upon the bioelectric activity of spinal cord.
    Nicolov N
    Folia Med (Plovdiv); 1967; 9(5):249-56. PubMed ID: 4301628
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure-activity relationships of the adrenocorticotropins and melanotropins: the synthetic approach.
    Ramachandran J; Choh Hao Li
    Adv Enzymol Relat Areas Mol Biol; 1967; 29():391-477. PubMed ID: 4302240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.